Bazanella, 2018 - Google Patents

Impact of early life intervention with four Bifidobacterium spp. on the infant faecal microbiota

Bazanella, 2018

View PDF
Document ID
14813715688837360254
Author
Bazanella M
Publication year

External Links

Snippet

Colonization of the human intestinal tract is a complex process influenced by many factors such as mode of delivery and type of feeding. The succession of microbial species in the developing gut may be driven by the addition of bacteria to the infant's diet. However, the …
Continue reading at mediatum.ub.tum.de (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Similar Documents

Publication Publication Date Title
Bazanella et al. Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome
AU2019204819B2 (en) Compositions comprising bacterial strains
Arboleya et al. Gut bifidobacteria populations in human health and aging
Cresci et al. Gut microbiome: what we do and don't know
Wang et al. Human microbiota-associated swine: current progress and future opportunities
EP2033529B1 (en) Synbiotic composition for infants
Krumbeck et al. In vivo selection to identify bacterial strains with enhanced ecological performance in synbiotic applications
Quin et al. Human behavior, not race or geography, is the strongest predictor of microbial succession in the gut bacteriome of infants
US20130195820A1 (en) Use of blood group status iii
Estorninos et al. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial
Blatchford et al. Prebiotic mechanisms, functions and applications-A review.
US20240306690A1 (en) Mixture of hmos and bifidobacteria
de Cuevillas et al. Fecal microbiota relationships with childhood obesity: a scoping comprehensive review
US20240050494A1 (en) Probiotics compositions and method of using the same to enhance growth and social function in children
Xu et al. The human microbiota associated with overall health
Mogna et al. Capability of the two microorganisms Bifidobacterium breve B632 and Bifidobacterium breve BR03 to colonize the intestinal microbiota of children
Bondue et al. Effect of Bifidobacterium crudilactis and 3′-sialyllactose on the toddler microbiota using the SHIME® model
AboNahas et al. Trust your gut: the human gut microbiome in health and disease
Park et al. Comprehensive analysis of the effect of probiotic intake by the mother on human breast milk and infant fecal microbiota
Yang et al. Precise strategies for selecting probiotic bacteria in treatment of intestinal bacterial dysfunctional diseases
Chawla et al. Gut microbiome dysbiosis in malnutrition
Mangwana The in vitro faecal evaluation of prebiotic effects of rooibos phenolic compounds on the gut microbiota of vervet monkeys (Chlorocebus pygerythrus)
Bazanella Impact of early life intervention with four Bifidobacterium spp. on the infant faecal microbiota
Morelli et al. Prebiotics, probiotics, and synbiotics: a bifidobacterial view
EP4251183A1 (en) Methods of preventing, delaying or ameliorating atopic diseases